SB 1328 Hawaii Senate · 2020 Regular Session

RELATING TO PRESCRIPTION DRUGS.

Summary

Requires that if a proposed increase in the wholesale price of certain drugs would result in a 16% or more price increase over a 2year period, the drug manufacturer shall notify various drug insurance providers.

Bill status passed 3 of 5 stages cleared

Introduction

Jan 2019

Committee Review

Mar 2019

Senate Passage

Mar 2019

House Passage

Governor

Introduced Jan 24, 2019 Last action Dec 1, 2019

Floor votes

How they voted

This bill passed the Senate. No roll call record of that vote is available.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 19, 2019

Lower · Passed

The committee(s) on HLT recommend(s) that the measure be deferred.

lower

Mar 7, 2019

Committee

Referred to HLT, CPC, referral sheet 27

lower

Mar 1, 2019

Introduced

Received from Senate (Sen. Com. No. 25).

lower

Mar 1, 2019

Upper · Passed

Passed Third Reading. Ayes, 24; Aye(s) with reservations: none . Noes, 0 (none). Excused, 1 (Senator(s) Harimoto). Transmitted to House.

upper

Feb 15, 2019

Upper · Passed

The committee(s) on CPH recommend(s) that the measure be PASSED, UNAMENDED. The votes in CPH were as follows: 5 Aye(s): Senator(s) Baker, J.Keohokalole, Ruderman, L. Thielen, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 2 Excused: Senator(s) S. Chang, Nishihara.

upper

Feb 11, 2019

Upper · Passed

The committee(s) on CPH has scheduled a public hearing on 02-15-19 9:30AM in conference room 229.

upper

Jan 28, 2019

Committee

Referred to CPH.

upper

Jan 24, 2019

Introduced

Introduced.

upper

3 primary · 0 co-sponsors